
Personalis PSNL
€ 5.61
-0.15%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Personalis DPO 2011-2026 | PSNL
DPO Jährlich Personalis
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.3 | 91.7 | 77.9 | 59.4 | 48.8 | 62.1 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 91.7 | 48.8 | 67.9 |
DPO Vierteljährlich Personalis
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.4 | 65.4 | 48.7 | - | 60.2 | 60 | 78.4 | - | 55 | 75.8 | 76.8 | - | 39.8 | 40.1 | 89.6 | - | 52.1 | 52.2 | 50.3 | - | 52.3 | 51.1 | 47.2 | - | 58.1 | 67.5 | 62.9 | - | 83.5 | 46.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 89.6 | 39.8 | 60.4 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
50.1 | $ 118.69 | -0.9 % | $ 36.1 B | ||
|
Burning Rock Biotech Limited
BNR
|
125 | $ 21.78 | 5.93 % | $ 234 M | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 518.86 | 0.06 % | $ 15 B | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 22.16 | 26.1 % | $ 1.18 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
19.7 | $ 8.14 | -6.28 % | $ 1.04 B | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.29 | -1.38 % | $ 2.01 B | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 1.46 | 2.46 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 24.59 | -0.12 % | $ 683 M | ||
|
Senseonics Holdings
SENS
|
68 | $ 6.78 | -1.74 % | $ 283 M | ||
|
Soleno Therapeutics
SLNO
|
1.44 K | $ 52.55 | -0.04 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
51.8 | $ 1.4 | 0.36 % | $ 92.3 M | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 178.08 | -1.37 % | $ 8.83 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 517.85 | -2.6 % | $ 195 B | ||
|
Danaher Corporation
DHR
|
65.4 | $ 194.37 | -1.9 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
33 | $ 2.2 | - | $ 9.73 M | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.69 | -2.42 % | $ 61.9 M | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 55.84 | -3.09 % | $ 3.34 B | ||
|
Illumina
ILMN
|
56.3 | $ 132.01 | -0.19 % | $ 21 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 16.19 | 0.12 % | $ 490 M | ||
|
Guardant Health
GH
|
48.6 | $ 84.8 | -0.07 % | $ 10.6 B | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
1.29 K | $ 2.82 | -3.75 % | $ 91.5 K | ||
|
Biomerica
BMRA
|
32.4 | $ 2.18 | 3.32 % | $ 5.01 M | ||
|
Waters Corporation
WAT
|
102 | $ 319.4 | -2.09 % | $ 19 B | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 115.49 | -0.87 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 266.74 | - | $ 22.2 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 5.03 | -3.06 % | $ 466 M | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 83.43 | -0.61 % | $ 5.63 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 192.03 | 0.32 % | $ 21.3 B |